Please login to the form below
ViiV Healthcare
Want to know which agency did which ad? Search using one of the options below.
« Previous page
1
Next page »
Agency:
Torre Lazur McCann
Product:
Kivexa
Client:
ViiV Healthcare
Therapy area:
Infections and Infestations
Agency:
Torre Lazur McCann
Product:
Kivexa
Client:
ViiV Healthcare
Therapy area:
Infections and Infestations
« Previous page
1
Next page »
COVID-19 Updates and Daily News
Featured jobs
-
CEO Pricing & Market Access, UK
-
Six figure salary
-
Omnichannel Strategy Consultant
-
Competitive Salary
-
Senior Account Manager
-
Competitive salary offered
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- US demand for COVID-19 antibody treatments rising fast
- Data shows patients treated with Biogen's MS therapies mount an effective antibody response to COVID-19 vaccination
- EU “still interested” in Valneva COVID vaccine despite UK snub
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Unlocking the Potential of Electronic Medical Records Using Artificial Intelligence
- Valneva COVID-19 vaccine more effective than AZ
- Real-world data highlights flu vaccine efficacy
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- Vertex moves ahead with its bid to develop a curative treatment for type 1 diabetes
- Best practice in UK diabetes care recognised at prestigious national awards
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
- Merck and Ridgeback request EUA from US FDA for COVID-19 drug molnupiravir
- The Future of eHealth: Contactless Health Monitoring
- Janssen’s RSV vaccine provides high protection against respiratory infections
- Novo Nordisk settles US insulin pricing dispute for $100m
- Four Health announces a pair of internal promotions
